Skip to main content
Download PDF
Download ePub

Variations in hepatic lipid species of age-matched male mice fed a methionine-choline-deficient diet and housed in different animal facilities

Lipids in Health and Disease volume 18, Article number: 172 (2019) Cite this article

Abstract

Background

Non-alcoholic steatohepatitis (NASH) is a common disease and feeding mice a methionine-choline-deficient (MCD) diet is a frequently used model to study its pathophysiology. Genetic and environmental factors influence NASH development and liver lipid content, which was studied herein using C57BL/6 J mice bred in two different animal facilities.

Methods

Age-matched male C57BL/6 J mice bred in two different animal facilities (later on referred to as WT1 and WT2) at the University Hospital of Regensburg were fed identical MCD or control chows for 2 weeks. Hepatic gene and protein expression and lipid composition were determined.

Results

NASH was associated with increased hepatic triglycerides, which were actually higher in WT1 than WT2 liver in both dietary groups. Cholesterol contributes to hepatic injury but was only elevated in WT2 NASH liver. Ceramides account for insulin resistance and cell death, and ceramide species d18:1/16:0 and d18:1/18:0 were higher in the NASH liver of both groups. Saturated sphingomyelins only declined in WT1 NASH liver. Lysophosphatidylcholine concentrations were quite normal in NASH and only one of the 12 altered phosphatidylcholine species declined in NASH liver of both groups. Very few phosphatidylethanolamine, phosphatidylserine, and phosphatidylinositol species were comparably regulated in NASH liver of both animal groups. Seven of these lipid species declined and two increased in NASH. Notably, hepatic mRNA expression of proinflammatory (F4/80, CD68, IL-6, TNF and chemerin) and profibrotic genes (TGF beta and alpha SMA) was comparable in WT1 and WT2 mice.

Conclusions

Mice housed and bred in different animal facilities had comparable disease severity of NASH whereas liver lipids varied among the groups. Thus, there was no specific lipid signature for NASH in the MCD model.

Background

Non-alcoholic fatty liver disease (NAFLD) is a common diagnosis particularly in overweight patients. The progressive form, non-alcoholic steatohepatitis (NASH), may lead to liver cirrhosis and hepatocellular carcinoma [1, 2]. Both, hepatic steatosis and liver fibrosis, are heritable, and numerous genetic variants contribute to disease progression [3, 4]. Many of the genes identified so far have a role in lipid metabolism [3]. Liver steatosis is a characteristic feature of NAFLD and most of the accumulating lipids are triglycerides [1, 2]. Triglycerides are biologically inert lipids and protect the liver from lipotoxicity [5]. Indeed, inappropriate triglyceride synthesis in conjunction with disturbed homeostasis of further lipid classes act as harmful agents on liver cells [6].

Lipid metabolism is also influenced by the gut microbiome [7]. Intestinal bacteria modulate fat absorption, choline metabolism, bile acid and cholesterol homeostasis [7, 8]. Gut dysbiosis is related to obesity and NAFLD [9], but notably has a role in the pathophysiology of various diseases [10]. Gut bacteria composition is affected by diet, the genetic background and environmental factors like stress [11]. NAFLD risk may be also increased by infection with Helicobacter species which may alter the intestinal microbiome and gut inflammation [12].

There are several animal models to study the pathogenesis of NASH [13, 14]. Feeding rodents a methionine-choline-deficient (MCD) diet is a widely used approach [13, 14]. MCD diet induces hepatic steatosis, inflammation, and eventually liver fibrosis. Lack of methionine contributes to body weight loss, oxidative stress, inflammation and fibrosis whereas absence of choline mainly causes liver steatosis [15].

A study performed by Kim et al. compared C57BL/6 N mice originating from Korea, USA, and Japan with the MCD diet. There were no major differences of organ weights, liver steatosis and levels of alanine aminotransferase, aspartate aminotransferase, triglycerides, and cholesterol between the three mice groups [16]. Consistently, MCD diet induced hepatic triglyceride accumulation in different studies. However, NASH-associated changes of further lipid classes were less reproducible [17,18,19].

In NASH, hepatocytes displaying cholesterol crystals activated circumjacent Kupffer cells and thus contributed to disease progression [20]. In mice fed a MCD chow, liver cholesterol was increased in some but not all models [18, 19]. The ratio of hepatic phosphatidylcholine (PC) to phosphatidylethanolamine (PE) is important for membrane integrity and liver health, and was decreased in NASH [21]. Not all studies could identify reduced phosphatidylcholine in the liver of MCD diet fed rodents [17,18,19, 22].

Particular ceramide species are cytotoxic and contribute to liver cell death [23]. After all, hepatic ceramide levels were unchanged or induced in the liver of MCD diet fed mice [18, 19, 22]. High, low and normal sphingomyelin levels were detected in NASH liver [18, 19, 22]. In summary, results regarding changes of hepatic lipids in the different MCD models were inconsistent [17, 18, 22, 24].

Differences in gender, age, composition of the diets and feeding period most likely contributed to these variations [17, 18, 22, 25]. Breeding of mice in different facilities caused genetic divergences, and this may also modulate hepatic lipid composition and NASH progression [3, 26]. Rodents in animal facilities with unrestricted access had a higher bacterial diversity [27]. Gut microbiome composition changed when different rodents were housed in an animal facility [27]. Thus, environmental factors affect the gut microbiome, which may also influence NASH pathogenesis and hepatic lipid composition [7, 9].

Here we hypothesized that mouse substrains housed in separate animal facilities differentially respond to MCD diet. Therefore, age-matched male mice were fed identical control chows or MCD diets for 2 weeks. Hepatic expression of NASH-specific genes and liver lipid composition were determined.

Materials and methods

Animal handling

The male C57BL/6 J mice were originally from the Jackson Laboratory (Bar Harbor, USA). Mice of the parent generation which were bred for at least 20 generations in two different conventional animal units at the University Hospital of Regensburg are referred to as wild type (WT) 1 and WT2 animals. Fifteen mice (14 weeks old - 8 WT1 and 7 WT2) were fed the MCD diet (E15653–94, Ssniff, Soest, Germany) and eleven mice (14 weeks old - 6 WT1 and 5 WT2 animals) the respective control chow (E15654–04, Ssniff, Soest, Germany) for 2 weeks. Experiments involving WT1 mice were performed in October 2014 and studies with WT2 mice in August 2016. Composition of the diets was identical over time (personal communication with Ssniff). Body weights were measured shortly before the experiment, 7 and 14 days later. The animals were fasted for 12 h and were all killed between 8 and 10 am. Livers were excised and stored in fluid nitrogen immediately. To avoid refreezing of the samples aliquots of liver tissues were stored at − 80 °C until used for the experiments. Storage of tissues at this temperature for 7 months did not cause degradation of lipids [28].

Animal and laboratory experiments were done by the same researchers. Health monitoring in the animal facilities was performed in accordance with the recommendations of the Federation of European Laboratory Animal Science Associations (FELASA) [29]. Mouse hepatitis virus and Helicobacter spp. were detected in the facility where WT2 mice were housed but were never identified in the WT1 facility. Both facilities were barrier-free. Room temperature, light dark cycle, humidity, cages, bedding, and standard chows were identical. Further, number of mouse in a cage was similar. Different animal keepers were employed in the two facilities. While in facility 1 only rats and mice were housed there were also rabbits in facility 2. Mouse weighing can be done in the room where the cages were located in facility 1 whereas this was done in a separate room in facility 2.

Quantification of lipids

Lipid quantification was done by direct flow injection electrospray ionization tandem mass spectrometry (ESI–MS/MS) in positive ion mode as described in detail elsewhere [19, 30,31,32].

Quantification of all lipid classes was based on standard addition calibration, which includes various species to address response differences [32]. Total concentrations of the lipid classes were obtained by addition of the values of the single species. Lipid analysis of all livers was done in parallel. Lipid species are given in compliance with the published proposal for shorthand notation of lipid structures analyzed by mass spectrometry [33]. Glycerophospholipid notation assumes the presence of even numbered carbon chains. Sphingomyelin species annotation implicates that a sphingoid base d18:1 is present. Saturated species have no double bond in the amide linked fatty acid chain and the monounsaturated species have one double bond. Liver lipids are all given as nmol/mg wet weight. Lipid species where values of all animals were below 0.01 nmol/mg wet weight were regarded as doubtful and were not used. Data of WT1 mice have been partly published [19].

Triglycerides were measured with the colorimetric triglyceride quantification kit from BioVision (Heidelberg, Germany).

Oil red O staining

For the detection of neutral lipids, 5 μm-thick cryosections were fixed with formalin and stained with 0.3 g / 100 ml Oil Red O (Sigma, Taufkirchen, Germany) solution for 15 min at room temperature and then counterstained with hematoxylin for 1 min.

SDS-PAGE and immunoblotting

SDS-PAGE and immunoblotting were performed as described [30, 34]. Antibody for GAPDH was from New England Biolabs GmbH (Frankfurt am Main, Germany). Chemerin antibody was from R&D Systems (Wiesbaden, Germany).

Semiquantitative real-time PCR

Semiquantitative real-time PCR (LightCycler® FastStart DNA Master SYBR Green I kit from Roche, Mannheim, Germany) was performed as described [34]. Serial dilutions of cDNA (obtained from murine, hepatic RNA) were amplified in parallel to the respective samples to obtain a standard curve. Calculation of mRNA expression was done relative to the values of the standards. This approach is appropriate to correct for different PCR efficiencies, which have to be considered when analyzing different genes. Further, by using identical standards, PCRs performed at different times can be compared. Analysis of gene expression of mice fed the MCD diet and the respective controls was done at the same time. Primers to amplify F4/80, TGF beta, alpha SMA, CD68 and 18S rRNA were used as published recently [19]. TNF was analyzed as described [35]. Primers 5’ttc cat cca gtt gcc ttc tt 3′ and 5’ttc tgc aag tgc atc atc gt 3’were used for IL-6 analysis. Data of the WT1 animals have been published earlier [19].

Analysis of malondialdehyde

Malondialdehyde (Lipid Peroxidation (MDA) Assay Kit) was measured by a colorimetric assay from Abcam (Cambridge, UK).

Statistical analysis

Data are shown as boxplots (median value, the lower and upper quartiles and the range of the values). Statistical analysis was done by Kruskal-Wallis test (SPSS Statistics 25.0 program, IBM, Leibniz Rechenzentrum, München, Germany). A value of p < 0.05 was regarded as significant.

Results

Body weight change, fat pad weight and liver weight

Age-matched male C57BL/6 J mice housed in two different animal facilities at the University Hospital of Regensburg were fed the identical MCD diet or control chow for 2 weeks. In accordance with previous studies all of the mice fed the MCD diet lost body weight [14] without any differences between the two groups (Fig. 1a). Body weight change during these 2 weeks did not vary between mice kept in the different animal facilities. This suggests that food intake, although not measured, was similar. Accordingly, subcutaneous, epididymal and perirenal white adipose tissue weights were similarly reduced in both groups (Fig. 1b and data not shown). Liver to body weight ratios were comparable in all of the mice (Fig. 1c). In the liver of WT2 mice fed the control chow small lipid droplets were visible which were not detected in WT1 mouse liver. Large lipid droplets appeared in the liver of WT1 and WT2 mice fed the MCD diet (Fig. 1d, e). Liver triglyceride concentrations of both groups increased in NASH. Hepatic triglycerides tended to be higher in WT2 than WT1 mice fed the control chow and were significantly increased in WT2 compared to WT1 NASH liver (Fig. 1f). Malondialdehyde (MDA) levels as a surrogate marker of lipid peroxidation were higher in WT1 NASH liver when compared to WT2 NASH liver (Fig. 1g).

Fig. 1
figure 1

Body weight change, fat pad weight, liver weight, and hepatic triglyceride (TG) and malondialdehyde (MDA) levels in mice fed a methionine-choline-deficient (MCD) or control diet and housed in two different animal facilities (WT1, WT2).a Body weight (BW) at the end of the study relative to the initial weight in %. b Epididymal (Epi) fat pad weight normalized to BW. c Liver weight normalized to BW. d H&E stained liver of WT mice fed a control diet. Small lipid droplets appear in the liver of WT2 mice and are visible at higher magnification (second row). Large lipid droplets in the liver of MCD diet fed mice (third and fourth row). e Oil Red O stained liver. f Hepatic TG concentrations. g Hepatic MDA levels. Data of 5 to 8 animals per group are shown. * p < 0.05, ** p < 0.01

Full size image

Hepatic gene and protein expression

F4/80 and CD68 are genes expressed by macrophages and were induced in NASH liver [36]. CD68 mRNA expression was upregulated in NASH liver of both animal groups whereas F4/80 was not significantly changed (Fig. 2a, b). The mRNA levels of tumor necrosis factor (TNF) and interleukin-6 (IL-6) only increased significantly in WT1 NASH liver (Fig. 2c, d). The mRNA expression of chemerin, a chemoattractant for immune cells [37], was not changed in NASH liver (Fig. 1e). Hepatic chemerin protein only increased in the liver of WT1 MCD diet fed mice (Fig. 2f, g). Regarding expression of profibrotic genes, the mRNA levels of alpha-smooth muscle actin (SMA) and transforming growth factor (TGF) beta showed similar trends in both groups (Fig. 2h, i). Large variability in gene / protein expression most likely accounts for the lack of significance in some of the experiments.

Fig. 2
figure 2

Hepatic expression of inflammatory and profibrotic genes in mice fed a methionine-choline-deficient (MCD) or control diet and housed in two different animal facilities (WT1, WT2).a Hepatic F4/80 mRNA. b Hepatic CD68 mRNA. c Hepatic TNF mRNA. d Hepatic IL-6 mRNA. e Hepatic chemerin mRNA. f Hepatic chemerin protein. g Quantification of hepatic chemerin protein. h Hepatic TGF beta mRNA. i Hepatic alpha SMA mRNA. Data of 5 to 8 animals per group are shown. * p < 0.05, ** p < 0.01

Full size image

Hepatic cholesterol species

Excess hepatic cholesterol contributes to cell death, inflammation and fibrosis in NASH [38]. Indeed, total levels of cholesteryl ester (CE) increased in the NASH liver of WT2 mice. This effect was not identified in WT1 mice. As a result, CE was higher in WT2 than WT1 NASH liver (Fig. 3a). Free cholesterol (FC) was unchanged in NASH liver but was higher in WT2 than WT1 NASH liver (Fig. 3b and Additional file 1: Table S1C).

Fig. 3
figure 3

Cholesteryl ester (CE), free cholesterol (FC), sphingomyelin (SM) and ceramide (Cer) in the liver of mice fed a methionine-choline-deficient (MCD) or control diet and housed in two different animal facilities (WT1, WT2). Concentrations are given as nmol/mg wet weight. a CE b FC c CE 22:6 d Total SM e SM 40:1 f SM 34:1 g Total Cer h Cer d18:1/16:0 and (i) Cer d18:1/22:0. Data of 5 to 8 animals per group are shown. * p < 0.05, ** p < 0.01

Full size image

Calculations of individual CE species revealed that simply CE 22:6 increased in WT1 NASH liver (Fig. 3c and Additional file 1: Table S1B). The CE species CE 14:0, 16:0, 18:3, 18:2, 18:1 and 18:0 were just induced in WT2 NASH liver (Additional file 1: Table S1A, B). In fact, the CE species CE 14:0, 16:1, 16:0, 18:3, 18:2 and 18:1 were high in WT2 NASH liver compared to WT1 NASH liver (Additional file 1: Table S1A). Interestingly, CE 18:3, 18:2 (Additional file 1: Table S1A) and CE 22:6 (Fig. 3c, Additional file 1: Table S1B) levels were more abundant in the liver of WT2 than WT1 controls.

Hepatic sphingolipids

Sphingolipids regulate various signaling pathways in NASH [39, 40]. Analysis of sphingomyelin (SM) levels in MCD-NASH livers showed divergent results [18, 19, 22]. Current analysis revealed that SM levels were not significantly changed in NASH liver of both groups (Fig. 3d). Saturated SM species were low in WT1 NASH liver compared to the respective control animals (Additional file 1: Table S2B).

In WT1 and WT2 NASH liver SM 40:2 (Additional file 1: Table S2A) and SM 40:1 (Fig. 3e and Additional file 1: Table S2A) were low whereas SM 36:1 (Additional file 1: Table S2A) was even high when compared to the respective control mice. In WT2 mouse liver SM 34:1 increased in NASH (Fig. 3f and Additional file 1: Table S2A). Comparison of SM species in WT1 and WT2 NASH liver revealed lower SM 34:1 (Fig. 3f and Additional file 1: Table S2A), 36:1 and 42:2 concentrations in the first group (Additional file 1: Table S2A). SM36:1 was further low in WT1 mice when compared to the respective WT2 mice fed the control chow (Additional file 1: Table S2A).

Degradation of SM can produce ceramide (Cer) which was found increased in NASH liver [17]. Unexpectedly, saturated (Additional file 1: Table S3B) and total Cer levels (Fig. 3g) were not induced in NASH liver. Cer d18:1/16:0 (Fig. 3h and Additional file 1: Table S3A) and Cer d18:1/18:0 (Additional file 1: Table S3A) increased in WT1 and WT2 NASH liver. In the WT2 mice Cer d18:1/23:0 and d18:1/24:1 were also higher (Additional file 1: Table S3A) whereas Cer d18:1/22:0 declined (Fig. 3i and Additional file 1: Table S3A). Comparison of the lipidome of WT1 and WT2 NASH liver revealed higher Cer d18:1/18:0 in the latter (Additional file 1: Table S3A). Of note, ceramide species were comparable in WT1 and WT2 controls (Fig. 3h, i and Additional file 1: Table S3A).

SM 40:1 is the most abundant SM species in the liver and was reduced in NASH (Fig. 3e and Additional file 1: Table S2A). The corresponding sphingomyelinase derived Cer species (Cer d18:1/22:0) was, however, not significantly changed in WT1 and even declined in WT2 NASH liver (Fig. 3i and Additional file 1: Table S3A). Cer d18:1/16:0 and the corresponding species SM 34:1 were both increased in NASH liver of WT2 mice (Fig. 3f, h and Additional file 1: Table S2A, S3A). This clearly illustrates that hepatic sphingomyelinase activity was not enhanced in the murine MCD models studied herein.

Hepatic lysophosphatidylcholine and phosphatidylcholine

Lysophosphatidylcholine (LPC) was found to contribute to lipoapoptosis in palmitate incubated hepatocytes [41]. Surprisingly, not a single LPC species was significantly changed in NASH liver (Fig. 4a - c and Additional file 1: Table S4A, B). All of the LPC species measured were similarly abundant in livers of WT1 mice and WT2 mice on a standard chow (Fig. 4a - c and Additional file 1: Table S4A, B). Compared to WT1 MCD diet fed mice LPC 16:0 (Fig. 4b and Additional file 1: Table S4A) and LPC 18:1 (Additional file 1: Table S4A), and thus saturated and monounsaturated LPC, were higher in WT2 NASH liver (Fig. 4b, c and Additional file 1: Table S4B, C).

Fig. 4
figure 4

Lysophosphatidylcholine (LPC), phosphatidylcholine (PC) and phosphatidylethanolamine (PE) in the liver of mice fed a methionine-choline-deficient (MCD) or control diet and housed in two different animal facilities (WT1, WT2). Concentrations are given as nmol/mg wet weight.a LPC 20:3 b LPC 16:0 c saturated (Sat) LPC d monounsaturated (MUFA) PC e PC 32:1 f PC 30:0 g PC to PE ratio h PE 36:5 and i PE 40:6. Data of 5 to 8 animals per group are shown. * p < 0.05, ** p < 0.01

Full size image

Phosphatidylcholine (PC) has a central role in the export of liver lipids to the blood [42]. Whereas monounsaturated PC was low in the NASH liver of WT1 animals compared to the controls, this was not the case in WT2 mice (Fig. 4d and Additional file 1: Table S5D). Species which were lower in WT1 NASH liver than controls (PC 32:1, 34:1, 36:1, 38:3, 38:2, 38:1, 40:4) were - with the exception of PC 32:1 (Fig. 4e and Additional file 1: Table S5A) - normal in the WT2 animals. Here, PC 30:0 (Fig. 4f and Additional file 1: Table S5A), PC 32:2, 36:3, 36:2 and 40:5 were actually induced (Additional file 1: Table S5A, B, D). Thus, PC 30:0 (Fig. 4f and Additional file 1: Table S5A), PC 32:2 (Additional file 1: Table S5A), PC 32:1 (Fig. 4e and Additional file 1: Table S5A), PC 34:1, 36:3, 36:2, 36:1 and 40:5 were high in WT2 NASH liver in comparison to WT1 NASH liver (Additional file 1: Table S5A - D). PC species 36:5, 36:4, 36:2, 38:3 and 40:5 were diminished in the liver of WT2 mice relative to WT1 animals kept on the control chow (Additional file 1: Table S5B - D).

Therefore, PC 32:1 was the only species concordantly changed in the NASH liver of WT1 and WT2 mice (Fig. 4e and Additional file 1: Table S5A).

Hepatic phosphatidylethanolamine, phosphatidylserine and phosphatidylinositol

Decreased PC to phosphatidylethanolamine (PE) ratio is associated with impaired membrane integrity and liver injury [21]. This ratio was not changed upon NASH development in both animal groups (Fig. 4g).

Total PE concentrations were not changed in NASH liver, and furthermore, were comparable between the mice housed in different facilities (data not shown). Various individual PE species (PE 36:5 (Fig. 4h and Additional file 1: Table S6A), PE 36:4, 38:5, 38:4, 38:3, 38:2, 40:4, 40:3, 42:6 (Additional file 1: Table S6A - C) were nevertheless reduced in the NASH liver of WT1 animals. Anyhow, PE 40:6 was induced in WT1 and WT2 NASH liver (Fig. 4i and Additional file 1: Table S6C). In the WT2 NASH liver PE 36:1, 40:7, 40:6 and 40:5 were also higher whereas PE 34:2 and 36:5 were low when compared to the WT2 controls (Additional file 1: Table S6A - C). In contrast to WT1 NASH liver, PE 36:3, 36:2, 36:1 (Additional file 1: Table S6A - B), PE 40:6 (Fig. 4i and Additional file 1: Table S6C) and PE 40:5 (Additional file 1: Table S6C) were higher in WT2 mice.

PE 36:5 (Fig. 4h and Additional file 1: Table S6A), PE 38:5. 38:3, 38:2, 40:4 and 42:6 were lower in the liver of WT2 compared to WT1 mice fed the control chow (Additional file 1: Table S6A - D).

Of the 20 analyzed PE species solely PE 36:5 and 40:6 were comparable changed in NASH liver of both cohorts (Fig. 4h, i).

Phosphatidylserine (PS) levels differed markedly in the liver of mice fed the control chow. PS 36:2, 38:5, 38:4, 38:3 (Additional file 1: Table S7A, B), PS 40:5 (Fig. 5a and Additional file 1: Table S7B) and MUFA PS (Fig. 5b and Additional file 1: Table S7B) were higher in WT1 mice. In NASH liver PS 40:5 was the only species which differed between the two groups, and was higher in WT2 compared to WT1 mice (Fig. 5a and Additional file 1: Table S7B).

Fig. 5
figure 5

Phosphatidylserine (PS) and phosphatidylinositol (PI) in the liver of mice fed a methionine-choline-deficient (MCD) or control diet and housed in two different animal facilities (WT1, WT2). Concentrations are given as nmol/mg wet weight. a PS 40:5 b Monounsaturated (MUFA) PS c PS 36:4 d PI 40:4 e PI 34:2 and f PI 40:5. Data of 5 to 8 animals per group are shown. * p < 0.05, ** p < 0.01

Full size image

While most PS species (PS 36:4, 38:5, 38:4, 38:3) declined in WT1 NASH liver compared to the respective control animals, PS 40:6 was induced (Additional file 1: Table S7A, B). In WT2 animals PS 36:4 (Fig. 5c and Additional file 1: Table S7A) and PS 38:4 (Additional file 1: Table S7A) were reduced and PS 36:2, 40:6 (Additional file 1: Table S7A, B) and PS 40:5 (Fig. 5a and Additional file 1: Table S7B) were increased. Hence, three of the 11 measured PS species (PS 36:4 (Fig. 5c and Additional file 1: Table S7A), 38:4 and 40:6 (Additional file 1: Table S7A, B) were concordantly changed in NASH liver of both animal groups.

Several phosphatidylinositol species namely PI 38:5, 38:3 (Additional file 1: Table S8B) and PI 40:4 (Fig. 5d and Additional file 1: Table S8B) were low in WT2 compared to WT1 liver in the control group. In the MCD diet fed animals there was no difference in any of the hepatic PI species (Fig. 4d - f and Additional file 1: Table S8A, B). In NASH liver PI 34:2 (Fig. 5e), PI 36:4 (Additional file 1: Table S8A), PI 38:3 (Additional file 1: Table S8B) and PI 40:4 (Fig. 5d and Additional file 1: Table S8B) decreased in both animal groups. PI 38:5 (Additional file 1: Table S8B) and PI 40:5 (Fig. 5f) only declined in WT1 mice in NASH. Therefore, four (PI 34:2, PI 36:4, PI 38:3, PI 40:4) of the 12 analyzed PI species declined in the NASH liver of all of the animals.

Discussion

Lipidomics uses techniques such as mass spectrometry and chromatography to quantify different lipid species and was applied to analyze lipid composition of NASH liver [43,44,45]. The present study illustrated that mice bred and housed in two different animal facilities showed marked differences in their hepatic lipidome when fed a NASH inducing diet. Very few lipid species were similarly altered in NASH liver of both groups and may be causally linked to disease pathogenesis. Of note, NASH disease severity did not differ between the groups.

Mice fed the MCD diet had increased triglycerides in the liver [22, 46, 47] and this was also found in the present study. WT2 mice had about two-fold higher triglyceride levels than WT1 animals irrespective of the diet. Lipid peroxidation as a marker of oxidative stress was markedly lower in the NASH liver of the WT2 mice. Further, the expression of inflammatory genes tended to be less prominent in WT2 NASH liver. Attempts to block hepatic triglyceride storage caused increased oxidative stress, inflammation and liver injury [5] showing that appropriate triglyceride synthesis is a protective mechanism in the steatotic liver. Lower triglyceride levels in WT1 mice may thus favor inflammation and fibrosis in NASH liver.

Upregulated and unchanged IL-6 mRNA expression in MCD-NASH liver were identified in the different mouse groups analyzed herein and was also reported in separate studies by others [46, 47]. Chemerin was found increased in NASH liver of MCD diet fed rodents [48] and was also higher in one of the present models. The analyzed genes and chemerin protein were, however, similarly expressed in WT1 and WT2 NASH liver suggesting that disease severity did not markedly differ between the two groups.

The two so far published comprehensive human studies analyzing the liver lipidome described a decline of hepatic PC levels in NASH liver [43,44,45]. Total PC was not reduced in the animals studied herein, and PC 32:1 was the only PC species concordantly reduced in the liver of WT1 and WT2 mice upon MCD diet. Choline deficient chows could not deplete hepatic PC levels, and synthesis by the CDP-choline pathway and PE methylation was normal [49, 50]. NASH development was not advanced by low hepatic PC levels in rodents [51]. The ratio of PC to PE is an established marker of membrane integrity [21] but was normal in the NASH liver of the mice studied herein.

In WT1 NASH mice various PC and PE species were reduced. Indeed, only PE 36:5 was diminished whereas PE 40:6 was induced in the NASH liver of both animal groups. Another study by Najt et al. could not identify higher PE 40:6 in MCD-NASH liver whereas PE 36:5 was not measured [18]. Therefore, these two PE species can not be considered as to be causal for NASH pathogenesis. Likewise, lipidomic analysis of human NASH livers revealed discordant results. One study showed a decrease of the phospholipid classes PE, PI and PS in NASH liver whereas levels were quite normal in the NASH patients enrolled in a second analysis [43, 45]. Total hepatic PS levels were also unaffected in the MCD diet fed mice studied herein. A total number of 11 PS species was analyzed and three of them were concordantly changed in NASH liver of both animal groups (PS 36:4, 38:4, 40:6). PS 40:6 was about two-fold higher in the NASH liver. Najt et al. even described a more than 20-fold increase of this lipid species. PS 36:4 and 38:4 were not changed in their experimental model [18]. This principally argues against a causal connection between these individual phospholipid species and NASH.

Phosphatidylinositol species mostly declined in NASH liver and four of the 12 measured molecules were reduced in WT1 and WT2 NASH liver. Three of the five analyzed PI species were also low in the NASH liver analyzed in a separate study [18]. Diminished PI levels were further reported in human NASH [43] and future studies have to clarify whether the decline of these lipids has a causal role in NAFLD progression.

LPC species were not regulated in MCD-NASH liver. A separate analysis nevertheless identified strongly elevated LPC in the liver of MCD diet and high fat diet fed mice [52]. This suggests that hepatic LPC levels were modified by diet, genetics and / or housing conditions [53] but were not mandatory for NASH pathogenesis.

Total SM concentration was depleted in human NASH liver in one study while a second analysis described normal levels [43, 45]. Total SM concentrations were not changed in the experimental model studied herein. Three SM species were concordantly altered in NASH liver of both groups and SM 40:2 was similarly changed in the MCD diet fed mice in a separate study [18]. Ceramide content was found higher in human NASH liver whereas a separate study described unchanged or lower levels [39, 43].

Specific hepatic sphingolipid species were associated with insulin resistance in patients with NASH [39, 54]. Cer d18:1/16:0 produced by ceramide synthase 6 is a key metabolite in obesity associated insulin resistance [55]. This lipid was induced in NASH liver of both mouse groups studied. However, MCD diet associated weight loss improves insulin sensitivity [56] demonstrating that the nearly 2.5 fold hepatic increase of this ceramide species may not suffice to cause insulin resistance.

A common variant in patatin-like phospholipase domain containing protein 3 (I148M) was associated with hepatic steatosis whereas insulin response was quite normal [57]. Though concentrations of hepatic ceramides and saturated fatty acids, which were supposed to contribute to liver disease, were comparable to the respective controls, these patients developed NASH [54, 57]. This principally challenges the causative role of individual hepatic lipids like distinct ceramide species herein.

Cholesterol and especially FC is supposed to contribute to hepatocyte death and NASH [38]. FC was normal in the liver of the MCD diet fed mice and CE levels were only higher in WT2 NASH liver. Individual CE species were changed in WT1 and WT2 liver whereas a common effect in NASH was not been identified. FC contributes to lipotoxicity, inflammation and fibrogenesis and was found increased in human NASH [38, 45] and in WT2 NASH liver. Comparable hepatic expression of inflammatory and profibrotic genes in WT1 and WT2 NASH liver excluded differences in hepatic injury. Cholesterol may thus have a minor if any role in MCD diet induced hepatic injury. Human analysis described a gradual increase of C16 and C18 CE species from normal to steatotic to NASH liver [43]. Though cholesterol may contribute to NASH pathogenesis in a subgroup of patients its role in murine NASH seems to be different. In mice the majority of systemic cholesterol is carried in high density lipoprotein while in humans it is mostly associated with low density lipoprotein [58] indicating major differences in human and rodent cholesterol metabolism.

Present study showed that most of the lipids were not concordantly changed in the two groups of mice though both developed NASH. CD68 as a marker of inflammation [59] and TGFbeta indicating liver fibrosis [60] were comparably induced in the liver of the MCD diet fed mice. There was no difference in hepatic chemerin protein, hepatic F4/80, TNF, IL-6 or alpha SMA mRNA in the NASH liver of WT1 and WT2 mice. Further, body weight and fat mass loss which contribute to liver steatosis and hepatic injury [61] were similar. In NASH liver of WT1 and WT2 mice about 50% of CE and SM species, nearly 30% of PC and PE species, 20% of LPC species and 10% of Cer and PS species differed between the two groups whereas levels of PI species were similar. Thus, PI composition may indeed contribute to NASH pathogenesis, a suggestion which has to be examined in future studies.

Current results using an experimental model and findings in human NASH liver argue against a specific NASH lipid signature [44]. Rather genetic and environmental factors seem to greatly affect the hepatic lipidome. One future experiment is to analyze the hepatic lipidome in both experimental diet groups of genetically identical mice housed in different facilities.

Breeding of animals in separate facilities generates substrains with 0.7–1.2 coding polymorphism for a year of separation [26] which may contribute to variations between the groups. Environmental factors differ in the two facilities and may affect the lipidome.

One obvious difference between the two experimental groups was infection with mouse hepatitis virus and Helicobacter spp. in one of the facilities. The virus causes an acute and self-limiting infection without clinical symptoms in adult mice [62]. Infected animals may have an altered immunological response which indeed can affect NASH pathogenesis [62]. Helicobacter spp. infections are subclinical at least in the relatively young mice studied [63]. Expression of inflammatory genes was, however, similar in both groups kept on the control and MCD diet. Histochemistry could not demonstrate abundant infiltration of immune cells into the liver. The mice used in the current study were either not infected or exhibited very mild disease. Whether infection with these pathogens has any effect on the liver lipidome is still unknown.

Liver samples of WT1 mice were stored for about 2 years longer than tissues obtained from WT2 mice. Storage of tissues at − 80 °C for 7 months did not cause any harm to cellular lipids [28]. Patients’ samples used for lipidomic analysis were collected within one to 2 years and an effect of storage time on data quality was not reported [64].

Regarding that mice fed the identical MCD diets display high lipidomic variability it is not surprising that very few LPC species were concordantly changed when serum levels of mice fed different high fat diets in three distinct animal facilities were compared [65]. Variations of lipids were also identified in the liver of mice fed the control diet in the current study. Nearly 45% of PS species varied in the two groups, and about 25 to 33% of the analyzed CE, PC, PE and PI species were also significantly altered. This shows a high diversity of the “normal” hepatic lipidome of mice fed the identical chows which may become more variable when feeding different diets [66, 67].

Analysis of the fecal microbiome revealed that various factors like vendor, chow, access to the barrier and even housing of different rodents in the facility significantly affected its composition [27]. Microbiota was not analyzed in this study but has to be considered in future research as a cause of variations in hepatic lipid composition.

Conclusions

Present study showed that hepatic lipid composition markedly differed in a commonly used NASH model when animals were breed and housed in different facilities. Current finding argues against a defined NASH lipid signature and postulates that several different NASH lipidomes exist.

Availability of data and materials

The datasets used or analyzed during the current study are available as supplementary table.

Abbreviations

CE:

Cholesteryl ester

Cer:

Ceramide

FC:

Free cholesterol

FELASA:

Federation of European Laboratory Animal Science Associations

IL-6:

Interleukin-6

LPC:

Lysophosphatidylcholine

MCD:

Methionine-choline-deficient

MDA:

Malondialdehyde

MUFA:

Monounsaturated

NAFLD:

Non-alcoholic fatty liver disease

NASH:

Non-alcoholic steatohepatitis

PC:

Phosphatidylcholine

PE:

Phosphatidylethanolamine

PI:

Phosphatidylinositol

PS:

Phosphatidylserine

PUFA:

Polyunsaturated

SM:

Sphingomyelin

SMA:

Smooth muscle actin

TNF:

Tumor necrosis factor

WT:

Wild type

References

  1. Buechler C, Wanninger J, Neumeier M. Adiponectin, a key adipokine in obesity related liver diseases. World J Gastroenterol. 2011;17:2801–11.

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Neuschwander-Tetri BA. Non-alcoholic fatty liver disease. BMC Med. 2017;15:45.

    Article  Google Scholar 

  3. Danford CJ, Yao ZM, Jiang ZG. Non-alcoholic fatty liver disease: a narrative review of genetics. J Biomed Res. 2018;32:389–400.

    PubMed  PubMed Central  Google Scholar 

  4. Loomba R, Schork N, Chen CH, Bettencourt R, Bhatt A, Ang B, Nguyen P, Hernandez C, Richards L, Salotti J, et al. Heritability of hepatic fibrosis and steatosis based on a prospective twin study. Gastroenterology. 2015;149:1784–93.

    Article  Google Scholar 

  5. Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK, Bhanot S, Monia BP, Li YX, Diehl AM. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology. 2007;45:1366–74.

    Article  CAS  Google Scholar 

  6. Marra F, Svegliati-Baroni G. Lipotoxicity and the gut-liver axis in NASH pathogenesis. J Hepatol. 2018;68:280–95.

    Article  CAS  Google Scholar 

  7. Kolodziejczyk AA, Zheng D, Shibolet O, Elinav E. The role of the microbiome in NAFLD and NASH. EMBO Mol Med. 2019;11:e9302.

  8. Molinero N, Ruiz L, Sanchez B, Margolles A, Delgado S. Intestinal Bacteria interplay with bile and cholesterol metabolism: implications on host physiology. Front Physiol. 2019;10:185.

    Article  Google Scholar 

  9. Milosevic I, Vujovic A, Barac A, Djelic M, Korac M, Radovanovic Spurnic A, Gmizic I, Stevanovic O, Djordjevic V, Lekic N, et al. Gut-liver Axis, gut microbiota, and its modulation in the Management of Liver Diseases: a review of the literature. Int J Mol Sci. 2019;20:395.

    Article  Google Scholar 

  10. Rinninella E, Raoul P, Cintoni M, Franceschi F, Miggiano GAD, Gasbarrini A, Mele MC. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms. 2019;7:14.

    Article  Google Scholar 

  11. Picchianti-Diamanti A, Rosado MM, D'Amelio R. Infectious agents and inflammation: the role of microbiota in autoimmune arthritis. Front Microbiol. 2017;8:2696.

    Article  Google Scholar 

  12. Castano-Rodriguez N, Mitchell HM, Kaakoush NO. NAFLD, helicobacter species and the intestinal microbiome. Best Pract Res Clin Gastroenterol. 2017;31:657–68.

    Article  CAS  Google Scholar 

  13. Machado MV, Michelotti GA, Xie G, de Almeida TP, Boursier J, Bohnic B, Guy CD, Diehl AM. Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease. PLoS One. 2015;10:e0127991.

    Article  Google Scholar 

  14. Schattenberg JM, Galle PR. Animal models of non-alcoholic steatohepatitis: of mice and man. Dig Dis. 2010;28:247–54.

    Article  CAS  Google Scholar 

  15. Caballero F, Fernandez A, Matias N, Martinez L, Fucho R, Elena M, Caballeria J, Morales A, Fernandez-Checa JC, Garcia-Ruiz C. Specific contribution of methionine and choline in nutritional nonalcoholic steatohepatitis: impact on mitochondrial S-adenosyl-L-methionine and glutathione. J Biol Chem. 2010;285:18528–36.

    Article  CAS  Google Scholar 

  16. Kim SH, Lim Y, Park JB, Kwak JH, Kim KJ, Kim JH, Song H, Cho JY, Hwang DY, Kim KS, Jung YS. Comparative study of fatty liver induced by methionine and choline-deficiency in C57BL/6N mice originating from three different sources. Lab Anim Res. 2017;33:157–64.

    Article  Google Scholar 

  17. Laggai S, Simon Y, Ranssweiler T, Kiemer AK, Kessler SM. Rapid chromatographic method to decipher distinct alterations in lipid classes in NAFLD/NASH. World J Hepatol. 2013;5:558–67.

    Article  Google Scholar 

  18. Najt CP, Senthivinayagam S, Aljazi MB, Fader KA, Olenic SD, Brock JR, Lydic TA, Jones AD, Atshaves BP. Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis. Am J Physiol Gastrointest Liver Physiol. 2016;310:G726–38.

    Article  Google Scholar 

  19. Rein-Fischboeck L, Haberl EM, Pohl R, Schmid V, Feder S, Krautbauer S, Liebisch G, Buechler C. Alpha-syntrophin null mice are protected from non-alcoholic steatohepatitis in the methionine-choline-deficient diet model but not the atherogenic diet model. Biochim Biophys Acta. 1863;2018:526–37.

    Google Scholar 

  20. Ioannou GN, Subramanian S, Chait A, Haigh WG, Yeh MM, Farrell GC, Lee SP, Savard C. Cholesterol crystallization within hepatocyte lipid droplets and its role in murine NASH. J Lipid Res. 2017;58:1067–79.

    Article  CAS  Google Scholar 

  21. Li Z, Agellon LB, Allen TM, Umeda M, Jewell L, Mason A, Vance DE. The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis. Cell Metab. 2006;3:321–31.

    Article  CAS  Google Scholar 

  22. Mas E, Danjoux M, Garcia V, Carpentier S, Segui B, Levade T. IL-6 deficiency attenuates murine diet-induced non-alcoholic steatohepatitis. PLoS One. 2009;4:e7929.

    Article  Google Scholar 

  23. Yeh MM, Brunt EM. Pathological features of fatty liver disease. Gastroenterology. 2014;147:754–64.

    Article  CAS  Google Scholar 

  24. Rein-Fischboeck L, Bajraktari G, Pohl R, Feder S, Eisinger K, Mages W, Haberl EM, Buechler C. Alpha-syntrophin dependent expression of tubulin alpha 8 protein in hepatocytes. J Physiol Biochem. 2018;74:511–52.

    Article  CAS  Google Scholar 

  25. Lee YH, Kim SH, Kim SN, Kwon HJ, Kim JD, Oh JY, Jung YS. Sex-specific metabolic interactions between liver and adipose tissue in MCD diet-induced non-alcoholic fatty liver disease. Oncotarget. 2016;7:46959–71.

    PubMed  PubMed Central  Google Scholar 

  26. Simecek P, Churchill GA, Yang H, Rowe LB, Herberg L, Serreze DV, Leiter EH. Genetic Analysis of Substrain Divergence in Non-Obese Diabetic (NOD) Mice. G3 (Bethesda). 2015;5:771–5.

    Article  CAS  Google Scholar 

  27. Rausch P, Basic M, Batra A, Bischoff SC, Blaut M, Clavel T, Glasner J, Gopalakrishnan S, Grassl GA, Gunther C, et al. Analysis of factors contributing to variation in the C57BL/6J fecal microbiota across German animal facilities. Int J Med Microbiol. 2016;306:343–55.

    Article  Google Scholar 

  28. Dill AL, Eberlin LS, Costa AB, Ifa DR, Cooks RG. Data quality in tissue analysis using desorption electrospray ionization. Anal Bioanal Chem. 2011;401:1949–61.

    Article  CAS  Google Scholar 

  29. Nicklas W, Baneux P, Boot R, Decelle T, Deeny AA, Fumanelli M, Illgen-Wilcke B. Recommendations for the health monitoring of rodent and rabbit colonies in breeding and experimental units. Lab Anim. 2002;36:20–42.

    Article  CAS  Google Scholar 

  30. Krautbauer S, Meier EM, Rein-Fischboeck L, Pohl R, Weiss TS, Sigruener A, Aslanidis C, Liebisch G, Buechler C. Ceramide and polyunsaturated phospholipids are strongly reduced in human hepatocellular carcinoma. Biochim Biophys Acta. 1861;2016:1767–74.

    Google Scholar 

  31. Liebisch G, Drobnik W, Reil M, Trumbach B, Arnecke R, Olgemoller B, Roscher A, Schmitz G. Quantitative measurement of different ceramide species from crude cellular extracts by electrospray ionization tandem mass spectrometry (ESI-MS/MS). J Lipid Res. 1999;40:1539–46.

    CAS  PubMed  Google Scholar 

  32. Liebisch G, Lieser B, Rathenberg J, Drobnik W, Schmitz G. High-throughput quantification of phosphatidylcholine and sphingomyelin by electrospray ionization tandem mass spectrometry coupled with isotope correction algorithm. Biochim Biophys Acta. 2004;1686:108–17.

    Article  CAS  Google Scholar 

  33. Liebisch G, Vizcaino JA, Kofeler H, Trotzmuller M, Griffiths WJ, Schmitz G, Spener F, Wakelam MJ. Shorthand notation for lipid structures derived from mass spectrometry. J Lipid Res. 2013;54:1523–30.

    Article  CAS  Google Scholar 

  34. Bauer S, Wanninger J, Schmidhofer S, Weigert J, Neumeier M, Dorn C, Hellerbrand C, Zimara N, Schaffler A, Aslanidis C, Buechler C. Sterol regulatory element-binding protein 2 (SREBP2) activation after excess triglyceride storage induces chemerin in hypertrophic adipocytes. Endocrinology. 2011;152:26–35.

    Article  CAS  Google Scholar 

  35. Pohl R, Rein-Fischboeck L, Meier EM, Eisinger K, Krautbauer S, Buechler C. Resolvin E1 and chemerin C15 peptide do not improve rodent non-alcoholic steatohepatitis. Exp Mol Pathol. 2015;98:295–9.

    Article  CAS  Google Scholar 

  36. Wang Y, Parlevliet ET, Geerling JJ, van der Tuin SJ, Zhang H, Bieghs V, Jawad AH, Shiri-Sverdlov R, Bot I, de Jager SC, et al. Exendin-4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration. Br J Pharmacol. 2014;171:723–34.

    Article  CAS  Google Scholar 

  37. Zabel BA, Kwitniewski M, Banas M, Zabieglo K, Murzyn K, Cichy J. Chemerin regulation and role in host defense. Am J Clin Exp Immunol. 2014;3:1–19.

    PubMed  PubMed Central  Google Scholar 

  38. Ioannou GN. The role of cholesterol in the pathogenesis of NASH. Trends Endocrinol Metab. 2016;27:84–95.

    Article  CAS  Google Scholar 

  39. Apostolopoulou M, Gordillo R, Koliaki C, Gancheva S, Jelenik T, De Filippo E, Herder C, Markgraf D, Jankowiak F, Esposito I, et al. Specific hepatic sphingolipids relate to insulin resistance, oxidative stress, and inflammation in nonalcoholic steatohepatitis. Diabetes Care. 2018;41:1235–43.

    Article  CAS  Google Scholar 

  40. Yew NS, Zhao H, Hong EG, Wu IH, Przybylska M, Siegel C, Shayman JA, Arbeeny CM, Kim JK, Jiang C, Cheng SH. Increased hepatic insulin action in diet-induced obese mice following inhibition of glucosylceramide synthase. PLoS One. 2010;5:e11239.

    Article  Google Scholar 

  41. Han MS, Park SY, Shinzawa K, Kim S, Chung KW, Lee JH, Kwon CH, Lee KW, Park CK, Chung WJ, et al. Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes. J Lipid Res. 2008;49:84–97.

    Article  CAS  Google Scholar 

  42. van der Veen JN, Kennelly JP, Wan S, Vance JE, Vance DE, Jacobs RL. The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease. Biochim Biophys Acta. 1859;2017:1558–72.

    Google Scholar 

  43. Chiappini F, Coilly A, Kadar H, Gual P, Tran A, Desterke C, Samuel D, Duclos-Vallee JC, Touboul D, Bertrand-Michel J, et al. Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients. Sci Rep. 2017;7:46658.

    Article  Google Scholar 

  44. Musso G, Cassader M, Paschetta E, Gambino R. Bioactive lipid species and metabolic pathways in progression and resolution of nonalcoholic steatohepatitis. Gastroenterology. 2018;155:282–302 e288.

    Article  CAS  Google Scholar 

  45. Puri P, Baillie RA, Wiest MM, Mirshahi F, Choudhury J, Cheung O, Sargeant C, Contos MJ, Sanyal AJ. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology. 2007;46:1081–90.

    Article  CAS  Google Scholar 

  46. Kammoun HL, Allen TL, Henstridge DC, Kraakman MJ, Peijs L, Rose-John S, Febbraio MA. Over-expressing the soluble gp130-fc does not ameliorate methionine and choline deficient diet-induced non alcoholic steatohepatitis in mice. PLoS One. 2017;12:e0179099.

    Article  Google Scholar 

  47. Zhang YH, Ma Q, Ding P, Li J, Chen LL, Ao KJ, Tian YY. S100A4 gene is crucial for methionine-choline-deficient diet-induced non-alcoholic fatty liver disease in mice. Yonsei Med J. 2018;59:1064–71.

    Article  CAS  Google Scholar 

  48. Buechler C. Chemerin in liver diseases. Endocrinol Metab Syndr. 2014;3:1–6.

    Google Scholar 

  49. Cui Z, Houweling M, Vance DE. Expression of phosphatidylethanolamine N-methyltransferase-2 in McArdle-RH7777 hepatoma cells inhibits the CDP-choline pathway for phosphatidylcholine biosynthesis via decreased gene expression of CTP:phosphocholine cytidylyltransferase. Biochem J. 1995;312(Pt 3):939–45.

    Article  CAS  Google Scholar 

  50. Kulinski A, Vance DE, Vance JE. A choline-deficient diet in mice inhibits neither the CDP-choline pathway for phosphatidylcholine synthesis in hepatocytes nor apolipoprotein B secretion. J Biol Chem. 2004;279:23916–24.

    Article  CAS  Google Scholar 

  51. Niebergall LJ, Jacobs RL, Chaba T, Vance DE. Phosphatidylcholine protects against steatosis in mice but not non-alcoholic steatohepatitis. Biochim Biophys Acta. 1811;2011:1177–85.

    Google Scholar 

  52. Pathil A, Mueller J, Warth A, Chamulitrat W, Stremmel W. Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease. Hepatology. 2012;55:1369–78.

    Article  CAS  Google Scholar 

  53. Suarez-Garcia S, Arola L, Pascual-Serrano A, Arola-Arnal A, Aragones G, Blade C, Suarez M. Development and validation of a UHPLC-ESI-MS/MS method for the simultaneous quantification of mammal lysophosphatidylcholines and lysophosphatidylethanolamines in serum. J Chromatogr B Analyt Technol Biomed Life Sci. 2017;1055-1056:86–97.

    Article  CAS  Google Scholar 

  54. Luukkonen PK, Zhou Y, Sadevirta S, Leivonen M, Arola J, Oresic M, Hyotylainen T, Yki-Jarvinen H. Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease. J Hepatol. 2016;64:1167–75.

    Article  CAS  Google Scholar 

  55. Turpin SM, Nicholls HT, Willmes DM, Mourier A, Brodesser S, Wunderlich CM, Mauer J, Xu E, Hammerschmidt P, Bronneke HS, et al. Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance. Cell Metab. 2014;20:678–86.

    Article  CAS  Google Scholar 

  56. Rinella ME, Elias MS, Smolak RR, Fu T, Borensztajn J, Green RM. Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet. J Lipid Res. 2008;49:1068–76.

    Article  CAS  Google Scholar 

  57. Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, Boerwinkle E, Cohen JC, Hobbs HH. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2008;40:1461–5.

    Article  CAS  Google Scholar 

  58. Camus MC, Chapman MJ, Forgez P, Laplaud PM. Distribution and characterization of the serum lipoproteins and apoproteins in the mouse, Mus musculus. J Lipid Res. 1983;24:1210–28.

    CAS  PubMed  Google Scholar 

  59. Patouraux S, Rousseau D, Bonnafous S, Lebeaupin C, Luci C, Canivet CM, Schneck AS, Bertola A, Saint-Paul MC, Iannelli A, et al. CD44 is a key player in non-alcoholic steatohepatitis. J Hepatol. 2017;67:328–38.

    Article  CAS  Google Scholar 

  60. Yang L, Roh YS, Song J, Zhang B, Liu C, Loomba R, Seki E. Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice. Hepatology. 2014;59:483–95.

    Article  CAS  Google Scholar 

  61. Tanaka N, Takahashi S, Fang ZZ, Matsubara T, Krausz KW, Qu A, Gonzalez FJ. Role of white adipose lipolysis in the development of NASH induced by methionine- and choline-deficient diet. Biochim Biophys Acta. 1841;2014:1596–607.

    Google Scholar 

  62. FR H. Enterotropic mouse hepatitis virus. Lab Anim. 1997;31:97–115.

    Article  Google Scholar 

  63. Chichlowski M, Hale LP. Effects of helicobacter infection on research: the case for eradication of helicobacter from rodent research colonies. Comp Med. 2009;59:10–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  64. Tsai HI, Lo CJ, Zheng CW, Lee CW, Lee WC, Lin JR, Shiao MS, Cheng ML, Yu HP. A Lipidomics study reveals lipid signatures associated with early allograft dysfunction in living donor liver transplantation. J Clin Med. 2019;8:30.

    Article  Google Scholar 

  65. Eisinger K, Liebisch G, Schmitz G, Aslanidis C, Krautbauer S, Buechler C. Lipidomic analysis of serum from high fat diet induced obese mice. Int J Mol Sci. 2014;15:2991–3002.

    Article  Google Scholar 

  66. Puri P, Xu J, Vihervaara T, Katainen R, Ekroos K, Daita K, Min HK, Joyce A, Mirshahi F, Tsukamoto H, Sanyal AJ. Alcohol produces distinct hepatic lipidome and eicosanoid signature in lean and obese. J Lipid Res. 2016;57:1017–28.

    Article  CAS  Google Scholar 

  67. Skorve J, Hilvo M, Vihervaara T, Burri L, Bohov P, Tillander V, Bjorndal B, Suoniemi M, Laaksonen R, Ekroos K, et al. Fish oil and krill oil differentially modify the liver and brain lipidome when fed to mice. Lipids Health Dis. 2015;14:88.

    Article  Google Scholar 

Download references

Acknowledgements

The expert technical assistance of Elena Underberg is greatly appreciated.

Funding

This study was supported by the German Research Foundation (BU 1141/12–1 and BU 1141/13–1).

Author information

Author notes

  1. Lisa Rein-Fischboeck and Elisabeth M. Haberl contributed equally to this work.

Authors and Affiliations

  1. Department of Internal Medicine I, Regensburg University Hospital, D-93042, Regensburg, Germany

    Lisa Rein-Fischboeck, Elisabeth M. Haberl, Rebekka Pohl, Susanne Feder & Christa Buechler

  2. Institute of Clinical Chemistry and Laboratory Medicine, Regensburg University Hospital, Regensburg, Germany

    Gerhard Liebisch & Sabrina Krautbauer

Authors
  1. Lisa Rein-Fischboeck
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elisabeth M. Haberl
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rebekka Pohl
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Susanne Feder
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gerhard Liebisch
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sabrina Krautbauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Christa Buechler
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

CB and LRF designed the research, LRF, EMH, RP, SF, GL and SK conducted the research; CB and GL analyzed the data; CB wrote the manuscript which was reviewed by all authors.All authors read and approved the final manuscript.

Corresponding author

Correspondence to Christa Buechler.

Ethics declarations

Ethics approval

Animal experiments were approved by the University of Regensburg Laboratory Animal Committee. Procedures complied with the German Law on Animal Protection and the Institute for Laboratory Animal Research Guide for the Care and Use of Laboratory Animals, 1999. Experiments were conducted according to institutional and governmental regulations for animal use (Government of Unterfranken).

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Additional file

Additional file 1:

Tables. Lipids in the liver of WT1 and WT2 mice fed a control diet (WT1, WT2) or MCD diet (WT1 MCD, WT2 MCD). Concentrations are given as nmol/mg wet weight. The p-values C-MCD WT1 and C-MCD WT2 apply to the comparisons of normal to NASH liver in either WT1 or WT2 groups. C is the comparison of lipid species in the livers of WT1 and WT2 mice fed the control chow and MCD is the comparison of lipid species in the livers of WT1 and WT2 mice fed the MCD diet. * p < 0.05, ** p < 0.01. Monounsaturated, MUFA; polyunsaturated, PUFA; Sat; Saturated, Table S1a-c. Cholesteryl ester (CE) in the liver Table S2a, b Sphingomyelin (SM) Table S3a, b Ceramide d18:1 (Cer) Table S4a-c Lysophosphatidylcholine (LPC) Table S5a–e Phosphatidylcholine (PC). Table S6a–d Phosphatidylethanolamine (PE). Table S7a-c Phosphatidylserine (PS) Table S8a-c Phosphatidylinositol (PI). (DOCX 104 kb)

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rein-Fischboeck, L., Haberl, E.M., Pohl, R. et al. Variations in hepatic lipid species of age-matched male mice fed a methionine-choline-deficient diet and housed in different animal facilities. Lipids Health Dis 18, 172 (2019). https://doi.org/10.1186/s12944-019-1114-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12944-019-1114-4

Keywords

  • Ceramide
  • Cholesterol
  • Chemerin, Phosphatidylcholine

Lipids in Health and Disease

ISSN: 1476-511X